Harnessing Generative Chemistry: webinar
In this webinar, we ask;
‘Why have generative chemistry methods been unable to redefine modern drug discovery and compound idea generation?’ In this session we shed light on a typical shortcoming of generative methods related to prioritising promising over unsuitable directions for exploration.
Joe McDonald (Chief Data Officer at a stealth biotech and formerly Executive Director at BMS) and Peter Hunt (Director of Computational Chemistry at Optibrium Ltd and previously CADD Group Leader at Novartis and MSD) discuss experiences using generative methods and their ideas on how to close the gaps.
See how Optibrium’s Inspyra iteratively learns priorities for your projects, generating compound ideas tailored to your needs. Via your interactions, Inspyra guides generative chemistry and multi-parameter optimisation capabilities. It combines the explorative power of generative methods with your expert knowledge, helping you identify better compounds faster.
To hear the narration, please increase your speaker volume.